VP of R&D
Eyal is an Experienced technological Designer with a multidisciplinary knowledge in design, plastic, electronic and textiles. Eyal has led projects from idea to mass production with overseas partners, from the prototype stage to the production lines.
Mr. Michael Sahar has been engaged in the Bio-medical industry in Israel since 1991, focusing on regulatory affairs, quality assurance, clinical trials and product validation and testing. He has served in these capacities in several start-up companies, as an engineer as well as a director.
A strong record of revenue growth and an unrivaled ability to penetrate target markets as well as a history of successfully taking companies to market.
Co Founder & CTO
Nadav is an experienced medical device R&D manager, with an extensive understanding of regulation and process.
Graduate of the outstanding student's program at Segol School of Neuroscience.
Co Founder & CEO
Eli is an experienced manager with extensive experience in leading technology-oriented companies throughout various development, sales, and growth cycles. Additionally, Eli boasts significant experience with medical patents, manufacturing processes, and organizational efficiencies.
Head of Marketing
A Serial entrepreneur and early-stage investor in multiple startups pharma, medical devices, and MedTech, Mr. Solomon is charged with leading investor relations and strategy. Previously Mr. Solomon was a Venture Partner at Sequoia Capital and is a sought after Speaker and Author with articles published in media outlets like The Huffington Post and the WSJ. Early in his career, Mr. Solomon was a Sales and BD Executive at IDX Health (acquired by GE).
Bs.c Biomedical Engineering.
Founder and CEO of Spinol Medical, Key Advisor with more than 20 years in Medical device development, and management.
was most recently the Senior Vice President, Chief Regulatory Officer of Medtronic, and was responsible for all Medtronic global regulatory efforts. Prior to joining Medtronic, Dr. Alpert served as Vice President of Regulatory Sciences for C.R. Bard, Inc. She also previously worked at the FDA where she held a variety of positions in the Centers dealing with drugs and devices.